The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Open accessAbstract
Abstract Isoprostanes are emerging as a new class of biologically active products of arachidonic acid metabolism of potential relevance to human vascular disease. Their formation in vivo seems to reflect primarily, if not exclusively, a nonenzymatic process of lipid peroxidation. Enhanced urinary excretion of 8-iso-PGF 2α has been described in association with cardiac reperfusion injury and with cardiovascular risk factors, including cigarette smoking, diabetes mellitus, and hypercholesterolemia. Besides providing a likely noninvasive index of lipid peroxidation in these settings, measurements of specific F 2 isoprostanes in urine may provide a sensitive biochemical end point for dose-finding studies of natural and synthetic inhibitors of lipid peroxidation. Although the biological effects of 8-iso-PGF 2α in vitro suggest that it and other isoeicosanoids may modulate the functional consequences of lipid peroxidation, evidence that this is likely in vivo remains inadequate at this time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“F2-isoprostanes are generated from arachidonic acid through a process of nonenzymatic free radical-catalyzed lipid peroxidation, thus representing an established marker of oxidative stress.33”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hámberg, M., Svensson, J., & Samuelsson, B. O. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,973
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898
Tuomilehto, J., Vidgrén, G., Toivanen, L., Tuomilehto‐Wolf, E., Kohtamäki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M. J., & Koskela, P. U. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,691
The role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,369
Research works printed but not linked: 21
- 10.1161/atvb.16.7.831 · DOI
- 10.1161/circ.67.6.6342834 · DOI
- 10.1161/circ.80.5.2553296 · DOI
- 1986, Am J Physiol, 250, H372
- 10.1161/res.65.3.2548761 · DOI
- 10.1161/circ.86.6.1451239 · DOI
- 1997, Circulation, 96, 2492
- Reilly MP Delanty N O’Callaghan P Crean P Roy L FitzGerald GA. Increased generation of the F 2 isoprostanes IPF 2α -1 and 8-iso-PGF 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation . In press.
- 1995, J Invest Med, 43, 292A
- 10.1161/str.25.2.8303731 · DOI
- 10.1161/circ.94.1.19 · DOI
- 1996, J Invest Med, 44, 223A
- Ciabattoni G Consoli A Vitacolonna E Mezzetti A Santarone S Pennese E Falco A Davi G Patrono C. In vivo formation of 8-epi-prostaglandin F 2α in diabetes mellitus: effects of tight metabolic control and vitamin E supplementation. Thromb Haemost . In press. Abstract.
- Davi G Alessandrini P Mezzetti A Minotti G Bucciarelli T Constantini F Cipallone F Bittolo Bon G Ciabattoni G Patrono C. In vivo formation of 8-epi-PGF 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol . In press.
- Palinski W Witztum JL. Oxidative stress and diabetes mellitus. In: Schwartz CJ Born GVR eds. New Horizons in Diabetes Mellitus and Cardiovascular Disease . Rapid Science Publishers; 1996:81-93.
- 1992, Diabetes, 4, 61
- 10.1161/circ.87.6.8504494 · DOI
- 1994, Lancet, 344, 1383
- 1994, Nutrition, 10, 527
- 10.1161/circ.94.10.2434 · DOI
- 1995, J Biol Chem, 269, 17273
Cited by
Sorted by citations
Items 101–200 of 450
Greco, A., Minghetti, L., & Levi, G. (2000) · Neurochemical Research · doi:10.1023/a:1007608615682 · Cited by 103
Is the Emperor Wearing Clothes?
Heinecke, J. W. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0801.095084 · Cited by 101
Gaut, J. P. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00101-3 · Cited by 99
Raff, M., Tholstrup, T., Basu, S., Nonboe, P., Sørensen, M. T., & Straarup, E. M. (2008) · Journal of Nutrition · doi:10.1093/jn/138.3.509 · Cited by 98
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis
Dogné, J., Hanson, J., & Praticò, D. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.001 · Cited by 97
Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors
Roberts, C. K., Chen, A. K., & Barnard, R. J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.011 · Cited by 102
Early Activation of Vascular Endothelial Cells and Platelets in Obese Children
Desideri, G., Simone, M. D., Iughetti, L., Rosato, T., Iezzi, M. L., Marinucci, M. C., Cofini, V., Croce, G., Passacquale, G., Necozione, S., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1741 · Cited by 98
Cottone, S., Mulè, G., Nardi, E., Vadalà, A., Guarneri, M., Briolotta, C., Arsena, R., Palermo, A., Riccobene, R., & Cerasola, G. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.09.005 · Cited by 95
Oxidative stress, diet, and the etiology of preeclampsia
Scholl, T. O., Leskiw, M. J., Chen, X., Sims, M., & Stein, T. P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.6.1390 · Cited by 96
Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis
Pinto, A. V., Raimondo, D. D., Tuttolomondo, A., Buttà, C., Milio, G., & Licata, G. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802481192 · Cited by 99
In Vivo Lipid Peroxidation and Platelet Activation in Cystic Fibrosis
Ciabattoni, G., Davı̀, G., Collura, M., Iapichino, L., Pardo, F., Ganci, A., Romagnoli, R., Maclouf, J., & Patrono, C. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9911071 · Cited by 95
Self-citationIdentification and Measurement of Endogenous β-Oxidation Metabolites of 8-epi-Prostaglandin F2α
Chiabrando, C., Valagussa, A., Rivalta, C., Durand, T., Guy, A., Zuccato, E., Villa, P., Rossi, J., & Fanelli, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1313 · Cited by 95
Elevated level of free 8-iso-prostaglandin F2α in the decidua basalis of women with preeclampsia
Staff, A. C., Halvorsen, B. L., Ranheim, T., & Henriksen, T. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70110-9 · Cited by 94
Fukuda, Y. (2002) · Heart · doi:10.1136/heart.87.3.264 · Cited by 93
Buscemi, S., Verga, S., Tranchina, M. R., Cottone, S., & Cerasola, G. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02091.x · Cited by 95
Puccetti, L., Santilli, F., Pasqui, A. L., Lattanzio, S., Liani, R., Ciani, F., Ferrante, E., Ciabattoni, G., Scarpini, F., Ghezzi, A. R., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.006 · Cited by 89
Xu, S., Jiang, B., Maitland, K. A., Bayat, H., Gu, J., Nadler, J. L., Corda, S., Lavielle, G., Verbeuren, T. J., Zuccollo, A., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0831 · Cited by 90
Inflammatory mediators are associated with 1-year mortality in critical limb ischemia
Barani, J., Nilsson, J., Mattiasson, I., Lindblad, B., & Gottsäter, A. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.03.025 · Cited by 90
Determinants of Platelet Activation in Human Essential Hypertension
Minuz, P., Patrignani, P., Gaino, S., Seta, F., Capone, M. L., Tacconelli, S., Degan, M., Faccini, G., Fornasiero, A., Talamini, G., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000105109.44620.1b · Cited by 90
Self-citationRole of Platelets in Inflammation and Cancer: Novel Therapeutic Strategies
Dovizio, M., Alberti, S., Guillem‐Llobat, P., & Patrignani, P. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12156 · Cited by 89
Staff, A. C., Brække, K., Johnsen, G. M., Karumanchi, S. A., & Harsem, N. K. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.03.036 · Cited by 86
Leeuwenburgh, C., Hansen, P. A., Holloszy, J. O., & Heinecke, J. W. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.1.r128 · Cited by 87
Repeated Sauna Therapy Reduces Urinary 8-Epi-Prostaglandin F2.ALPHA.
Masuda, A., Miyata, M., Kihara, T., Minagoe, S., & Tei, C. (2004) · Japanese Heart Journal · doi:10.1536/jhj.45.297 · Cited by 86
Determinants of F2-isoprostane biosynthesis and inhibition in man
Davì, G., Falco, A., & Patrono, C. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.10.001 · Cited by 85
Self-citationRedox biomarkers in cardiovascular medicine
Galougahi, K. K., Antoniades, C. A., Nicholls, S. J., Channon, K. M., & Figtree, G. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv126 · Cited by 83
α-Tocopherol and Atherosclerosis
Kaul, N., Devaraj, S., & Jialal, I. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600102 · Cited by 85
Microcirculatory Dysfunction Induced by Cigarette Smoking
Lehr, H.-A. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00135.x · Cited by 86
Lawson, J. A., Li, H., Rokach, J., Adiyaman, M., Hwang, S., Khanapure, S. P., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29295 · Cited by 82
Self-citationHoffman‐Goetz, L., Pervaiz, N., Packer, N. H., & Guan, J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.05.001 · Cited by 80
Khaselev, N., & Murphy, R. C. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00211-1 · Cited by 80
Yang, H. H. C., van Breemen, C., & Chung, A. W. Y. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.10.005 · Cited by 79
F2-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: a Review
Subramanian, K., Muniandy, S., Qvist, R., & Ismail, I. S. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-266 · Cited by 79
l -Arginine Reverses p47phox and gp91phox Expression Induced by High Salt in Dahl Rats
Fujii, S., Zhang, L., Igarashi, J., & Kosaka, H. (2003) · Hypertension · doi:10.1161/01.hyp.0000094557.36656.d0 · Cited by 78
Determinants of platelet activation in Alzheimer's disease
Ciabattoni, G., Porreca, E., Febbo, C. D., Iorio, A. D., Paganelli, R., Bucciarelli, T., Pescara, L., Re, L. D., Giusti, C., Falco, A., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.011 · Cited by 77
Self-citationCRISTOFARO, R. D., Rocca, B., Vitacolonna, E., Falco, A., Marchesani, P., Ciabattoni, G., Landolfi, R., Patrono, C., & Davı̀, G. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00072.x · Cited by 74
Self-citationAdipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
Anfossi, G., Russo, I., Doronzo, G., Pomero, A., & Trovati, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/174341 · Cited by 76
Pamukçu, B., Oflaz, H., & Nişancí, Y. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.10.007 · Cited by 73
Role of Nadph Oxidase in Atherosclerosis
Violi, F., Basili, S., Nigro, C., & Pignatelli, P. (2008) · Future Cardiology · doi:10.2217/14796678.5.1.83 · Cited by 73
Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure
Hodgson, J. M., Puddey, I. B., Croft, K. D., Mori, T. A., Rivera, J., & Beilin, L. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00029-5 · Cited by 73
Antioxidant vitamins and their influence in diabetes mellitus
Hasanain, B., & Mooradian, A. D. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0110-6 · Cited by 74
Pitocco, D., Zaccardi, F., Tarzia, P., Milo, M., Scavone, G., Rizzo, P., Pagliaccia, F., Nerla, R., Franco, A. D., Manto, A., et al. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12041 · Cited by 73
Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein
Jialal, I. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1827 · Cited by 72
Baseline diene conjugation in LDL lipids:
Ahotupa, M. O., & Vasankari, T. J. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00201-4 · Cited by 71
King, C. C., Piper, M. E., Gepner, A. D., Fiore, M. C., Baker, T. B., & Stein, J. H. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308728 · Cited by 77
Martino, F., Loffredo, L., Carnevale, R., Sanguigni, V., Martino, E., Catasca, E., Zanoni, C., Pignatelli, P., & Violi, F. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0735 · Cited by 70
The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies
Gaussem, P., Reny, J., Thalamas, C., CHATELAIN, N., KROUMOVA, M., JUDE, B., Boneu, B., & Fiessinger, J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01468.x · Cited by 68
Ferroni, P., Vazzana, N., Riondino, S., Cuccurullo, C., Guadagni, F., & Davı̀, G. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4324 · Cited by 68
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus
Angiolillo, D. J., & Suryadevara, S. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.12.001 · Cited by 68
Miyata, K., Ohashi, N., Suzaki, Y., Katsurada, A., & Kobori, H. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04938.x · Cited by 68
Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients
Cottone, S., Mulè, G., Guarneri, M., Palermo, A., Lorito, M. C., Riccobene, R., Arsena, R., Vaccaro, F., Vadalà, A., Nardi, E., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn489 · Cited by 68
Pamukçu, B., Oflaz, H., Öncül, A., Umman, B., Mercanoğlu, F., Ozcan, M., Meriç, M., & Nişancí, Y. (2006) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-8952-4 · Cited by 68
Oxidative stress in patients with obstructive sleep apnea syndrome
Ntalapascha, M., Makris, D. A., Kyparos, A., Tsilioni, I., Κostikas, Κ., Gourgoulianis, K. I., Kouretas, D., & Zakynthinos, E. G. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0718-y · Cited by 66
Isoprostanes and Oxidative Stress in Off-Pump and On-Pump Coronary Bypass Surgery
Cavalca, V., Sisillo, E., Veglia, F., Tremoli, E., Cighetti, G., Salvi, L., Sola, A., Mussoni, L., Biglioli, P., Folco, G., et al. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.08.019 · Cited by 65
Scholz, H. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00538-8 · Cited by 66
Leitinger, N., Huber, J., Rizza, C., Mechtcheriakova, D., Bochkov, V. N., Koshelnick, Y., Berliner, J. A., & Binder, B. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0498fje · Cited by 64
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
Petrucci, G., Rizzi, A., Hatem, D., Tosti, G., Rocca, B., & Pitocco, D. (2022) · Antioxidants · doi:10.3390/antiox11071408 · Cited by 68
Mustad, V. A., Smith, C. A., Ruey, P., Edens, N. K., & DeMichele, S. J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.6.1237 · Cited by 63
Webb, A., Hardy, P., Peterkin, M., Lee, O., Shalley, H., Croft, K. D., Mori, T. A., Heine, R. G., & Bines, J. E. (2008) · Nutrition · doi:10.1016/j.nut.2008.05.004 · Cited by 62
Malek, A., Sager, R., & Schneider, H. (2001) · Placenta · doi:10.1053/plac.2001.0635 · Cited by 62
Inhibition of COX pathway in experimental myocardial infarction
SAITO, T. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.002 · Cited by 62
Pamukçu, B. (2006) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-9043-2 · Cited by 62
The vascular risk associations with migraine: Relation to migraine susceptibility and progression
Hamed, S. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.10.016 · Cited by 61
Anaphylaxis increases 8-iso-prostaglandin F2α release from guinea-pig lung in vitro
Montuschi, P., Currò, D., Ragazzoni∘, E., Preziosi, P., & Ciabattoni, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00859-0 · Cited by 60
Ohashi, N., Urushihara, M., Satou, R., & Kobori, H. (2010) · Hypertension Research · doi:10.1038/hr.2010.143 · Cited by 60
Shui, S., Wang, X., Chiang, J. Y., & Zheng, L. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215573391 · Cited by 64
RetractedThe High Atherosclerotic Risk Among Epileptics: the Atheroprotective Role of Multivitamins
Hamed, S. A., & Nabeshima, T. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05003x · Cited by 60
Wolfram, R. M., Oguogho, A., Palumbo, B., & Sinzinger, H. F. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.05.007 · Cited by 60
Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease
Mathur, S., Devaraj, S., & Jialal, I. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200203000-00003 · Cited by 59
8-Iso-Prostaglandin F 2α Reduces Trophoblast Invasion and Matrix Metalloproteinase Activity
Staff, A. C., Ranheim, T., Henriksen, T., & Halvorsen, B. L. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1307 · Cited by 58
Mehrabi, M. R. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00108-x · Cited by 58
Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia
Harsem, N. K., Brække, K., & Staff, A. C. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.11.014 · Cited by 57
Bitar, M. S., Al‐Saleh, E., & Al‐Mulla, F. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.01.033 · Cited by 57
Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea
Labbé, D., Teranishi, M.-A., Heß, A., Bloch, W., & Michel, O. (2004) · Hearing Research · doi:10.1016/j.heares.2004.10.002 · Cited by 56
Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets
Csiszár, A., Stef, G., Pacher, P., & Ungvari, Z. I. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0399 · Cited by 56
Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells
Jiang, H., McGiff, J. C., Quilley, J., Sacerdoti, D., Reddy, L. M., Falck, J. R., Zhang, F., Lerea, K. M., & Wong, P. Y.-K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403962200 · Cited by 55
Petrucci, G., Zaccardi, F., Giaretta, A., Cavalca, V., Capristo, E., Cardillo, C., Pitocco, D., Porro, B., Schinzari, F., TOFFOLO, G. M., et al. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14445 · Cited by 56
Bhattacharjee, S., Pennathur, S., Byun, J., Crowley, J. R., Mueller, D. M., Gischler, J., Hotchkiss, R. S., & Heinecke, J. W. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2557 · Cited by 55
Kim, J. Y., Hyun, Y. J., Jang, Y., Lee, B. K., Chae, J. S., Kim, S. E., Yeo, H. Y., Jeong, T., Jeon, D. W., & Lee, J. H. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.630 · Cited by 54
Burnett, A. L. “., Strong, T. D., Trock, B. J., Jin, L., Bivalacqua, T. J., & Musicki, B. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.09.005 · Cited by 54
Samuelsson, L., Gottsäter, A., & Lindgärde, F. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00264.x · Cited by 53
Antiplatelet therapy in type 2 diabetes mellitus
Angiolillo, D. J. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32807f2ad9 · Cited by 53
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
Zaccardi, F., Rizzi, A., Petrucci, G., Ciaffardini, F., Tanese, L., Pagliaccia, F., Cavalca, V., Ciminello, A., Habib, A., Squellerio, I., et al. (2016) · Diabetes · doi:10.2337/db15-0936 · Cited by 53
Self-citationPraticò, D., Rokach, J., & Tangirala, R. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730736.x · Cited by 54
Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist
Osende, J., Shimbo, D., Fuster, V., Dubar, M., & Badimón, J. J. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7933.2004.00639.x · Cited by 52
Serum total 8-iso-prostaglandin F2α: A new and independent predictor of peripheral arterial disease
Mueller, T., Dieplinger, B., Gegenhuber, A., Haidinger, D., Schmid, N., Roth, N., Ebner, F., Landl, M., Poelz, W., & Haltmayer, M. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.07.044 · Cited by 51
Role of 8-iso-prostaglandin F2α and 25-hydroxycholesterol in the pathophysiology of endometriosis
Sharma, I., Dhaliwal, L., Saha, S. C., Sangwan, S., & Dhawan, V. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.141 · Cited by 51
Nitenberg, A., Ledoux, S., Valensi, P. E., Sachs, R. N., & Antony, I. (2002) · Diabetes · doi:10.2337/diabetes.51.3.813 · Cited by 49
Ryu, Y., Reid, M. J., & Thomas, K. V. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.07.060 · Cited by 48
Suzaki, Y., Ozawa, Y., & Kobori, H. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.40 · Cited by 48
Oxidative stress, alpha-tocopherol therapy, and atherosclerosis
Harris, A., Devaraj, S., & Jialal, I. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0075-6 · Cited by 48
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Disease
Wu, F., Molinaro, P. F., & Chen, Y. (2014) · Current Environmental Health Reports · doi:10.1007/s40572-014-0011-2 · Cited by 47
Behr‐Roussel, D., Oudot, A., Caisey, S., Coz, O. L., Gorny, D., Bernabé, J., Wayman, C. P., Alexandre, L., & Giuliano, F. (2007) · European Urology · doi:10.1016/j.eururo.2007.11.018 · Cited by 47
Isoprostanes and other markers of peroxidation in atherosclerosis
Patrignani, P., & Tacconelli, S. (2005) · Biomarkers · doi:10.1080/13547500500215084 · Cited by 47
Yen, P.-L., Chen, B., Yang, F. L., & Lu, Y. (2009) · Nutrition · doi:10.1016/j.nut.2009.04.020 · Cited by 46
Lipid peroxidation and atherosclerosis in type II diabetes
Oranje, W. A., & Wolffenbuttel, B. H. R. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90050-1 · Cited by 46
Klings, E. S., Christman, B. W., McClung, J. P., Stucchi, A. F., McMahon, L. C., BRAUER, M., & Farber, H. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2101020 · Cited by 46
Wilson, S. H. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00225-4 · Cited by 46
Increased urinary F2-isoprostanes in patients with Crohn's disease
Cracowski, J., Bonaz, B. L., Bessard, G., Bessard, J., Anglade, C., & Fournet, J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05427.x · Cited by 45
Desideri, G., Croce, G., Tucci, M., Passacquale, G., Broccoletti, S., Valeri, L., Santucci, A., & Ferri, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030724 · Cited by 45
Pamukçu, B., Oflaz, H., Acar, R. D., Umman, S., Koylan, N., Umman, B., & Nişancí, Y. (2005) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-005-2318-1 · Cited by 45
Metadata
- Authors
- Patrono, C., & FitzGerald, G. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-11
- Volume
- 17
- Issue
- 11
- Pages
- 2309-2315
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2087724955
- Cited by
- 453
- References
- 61
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 6 · 2016: 9 · 2015: 11 · 2014: 8 · 2013: 10 · 2012: 15
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bayer
- Wellcome Trust
- European Commission
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P50HL054500, 1P50HL54500)
- National Center for Research Resources (MO1-RR-00040, M01RR000040)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- isoprostanes, lipid peroxidation, oxidative stress, arachidonic acid metabolism, atherothrombosis, urinary biomarkers, cardiovascular risk factors, smoking, diabetes mellitus, hypercholesterolemia, ischemia-reperfusion injury, lipid peroxidation inhibitors, dose-finding
- MeSH terms
- Antioxidants, Arteriosclerosis, Cardiovascular Diseases, Diabetes Mellitus, Free Radicals, Humans, Hyperlipidemias, Immunoassay, Indicator Dilution Techniques, Gas Chromatography-Mass Spectrometry, Platelet Aggregation, Prostaglandins F, Risk Factors, Thrombosis, Vasoconstrictor Agents, Lipid Peroxidation, Dinoprost, Biomarkers, Oxidative Stress, F2-Isoprostanes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review